ArticleClinical cancer research : an official journal of the American Association for Cancer Research2017

p53 Nongenotoxic Activation and mTORC1 Inhibition Lead to Effective Combination for Neuroblastoma Therapy.

Myrthala Moreno-Smith et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.